Persistent hyperparathyroidism affects renal outcomes and mortality. After kidney transplantation, cinacalcet is not approved as treatment for hyperparathyroidism. Parathyroidectomy, on the other hand, reverses electrolytes and mineral bone metabolism in almost all cases. Early parathyroidectomy may increase the chance of resolving hyperparathyroidism.A 58–year-old man with ESRD status post deceased donor kidney transplantation 3 years prior presented with bone aches. He had persistent hypercalcemia and hypophosphatemia secondary to hyperparathyroidism. Serum calcium ranged 9.3–11.4mg/dl and serum phosphorus was decreased with a lowest value of 2.1mg/dl. Intact PTH level was elevated to 487pg/ml and total 25–OH vitamin D was 20ng/ml. Bone d...
Tertiary hyperparathyroidism is a common cause of hypercalcemia after kidney transplant. We designed...
OBJECTIVE: To provide a review on current knowledge about the pathogenesis, epidemiology, and clinic...
Hypercalcemia (HC) has been variably reported in kidney transplanted (KTx) recipients (5-15%). Calci...
Copley JB, Wüthrich RP. Therapeutic management of post-kidney transplant hyperparathyroidism. Clin T...
Background Hyperparathyroidism is common in patients with chronic kidney disease with reduced renal ...
Introduction Tertiary hyperparathyroidism (tHPT), i.e., persistent HPT after kidney transplantation,...
Persistent hyperparathyroidism (HPT) after kidney transplantation (KTx) is associated with hypercalc...
Tertiary hyperparathyroidism (tHPT) most commonly refers to a persistent secondary hyperparathyroidi...
Background. Persistent hyperparathyroidism after renal transplantation affects bone and allografts. ...
Background. Treatment of persistent hyperparathyroidism in renal transplant patients resistant to ca...
Significant advances in immunosuppressive therapies have been made in renal transplantation, leading...
Background. Cinacalcet lowers plasma parathyroid hormone (PTH) levels in primary and secondary hyper...
Background. Cinacalcet rapidly normalizes serum calcium and reduces intact parathyroid hormone (PTH)...
Cinacalcet, a calcimimetic, was evaluated in persistent hyperparathyroidism after kidney transplanta...
Hyperparathyroidism is a common consequence of end-stage renal disease (ESRD). Patients with hyperpa...
Tertiary hyperparathyroidism is a common cause of hypercalcemia after kidney transplant. We designed...
OBJECTIVE: To provide a review on current knowledge about the pathogenesis, epidemiology, and clinic...
Hypercalcemia (HC) has been variably reported in kidney transplanted (KTx) recipients (5-15%). Calci...
Copley JB, Wüthrich RP. Therapeutic management of post-kidney transplant hyperparathyroidism. Clin T...
Background Hyperparathyroidism is common in patients with chronic kidney disease with reduced renal ...
Introduction Tertiary hyperparathyroidism (tHPT), i.e., persistent HPT after kidney transplantation,...
Persistent hyperparathyroidism (HPT) after kidney transplantation (KTx) is associated with hypercalc...
Tertiary hyperparathyroidism (tHPT) most commonly refers to a persistent secondary hyperparathyroidi...
Background. Persistent hyperparathyroidism after renal transplantation affects bone and allografts. ...
Background. Treatment of persistent hyperparathyroidism in renal transplant patients resistant to ca...
Significant advances in immunosuppressive therapies have been made in renal transplantation, leading...
Background. Cinacalcet lowers plasma parathyroid hormone (PTH) levels in primary and secondary hyper...
Background. Cinacalcet rapidly normalizes serum calcium and reduces intact parathyroid hormone (PTH)...
Cinacalcet, a calcimimetic, was evaluated in persistent hyperparathyroidism after kidney transplanta...
Hyperparathyroidism is a common consequence of end-stage renal disease (ESRD). Patients with hyperpa...
Tertiary hyperparathyroidism is a common cause of hypercalcemia after kidney transplant. We designed...
OBJECTIVE: To provide a review on current knowledge about the pathogenesis, epidemiology, and clinic...
Hypercalcemia (HC) has been variably reported in kidney transplanted (KTx) recipients (5-15%). Calci...